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Abstract
Background: Insufficient vigilance for renal insufficiency is associated with late referral, increased morbidity and mortality.
The present study examines whether increased vigilance for chronic kidney disease (CKD) leads to quicker referral to and
better follow-up by a nephrologist, and whether it is associated with an improved outcome.
Methods: Patients with an eGFR < 45 ml/min/1.73 m2 during hospitalisation at the Ghent University Hospital
were enrolled during a period of 100 days. The patients were interviewed about their awareness of CKD. Both
the patients and their general practitioner were subsequently informed about CKD. The primary endpoint was
the number of patients referred for nephrological follow-up within three months. The secondary endpoint was
need for dialysis and mortality from any cause one year after inclusion.
Results: Of the 72 included patients, 54 had proven CKD, with eGFR consistently < 45 ml/min/1.73 m2 during at
least three months before inclusion. Merely 65% was aware of having CKD and only 41% was in regular nephrological
follow-up. After intervention, the percentage of patients with CKD in follow-up increased from 41% to 71% (p = 0.002).
The proportion reaching the secondary endpoint was significant lower in the patients who were referred quickly than
in those who were not (p = 0.015). Similarly, the proportion was significant lower in the patients who received
nephrological follow-up than in those who did not (p = 0.006).
Conclusion: Vigilance for CKD is poor. Simple interventions to augment the vigilance for CKD, as presented in this study,
lead to a quicker referral to and follow-up by a nephrologist, which may result in better outcome.
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Background
Early detection, follow-up and treatment of CKD patients
reduce the morbidity and mortality and delay the progres-
sion of renal failure [1, 2]. Two thirds of the patients with
CKD stages 3, 4 or 5 require one or more medical inter-
ventions or therapy adjustments, including a better con-
trol of arterial hypertension, correction of anaemia,
management of mineral bone disorders or discontinuation
of nephrotoxic medications [3–7].
Active participation of patients in their own care is
critical [8, 9], but may be limited by the lack of
awareness and understanding of CKD [10], ensuing in late
referral [9]. A late referral to a multidisciplinary nephrology
team is associated with a worse outcome after the start of
dialysis and decreases the access to kidney transplantation
[11]. Longer and more intense nephrological follow-up of
patients who eventually undergo dialysis is commensurate
with better survival [9, 11–13]. In Belgium, a care path for
chronic renal insufficiency was developed in 2009 by the
National Institute for Health and Disability Insurance, in
order to tackle CKD in a multidisciplinary way and increase
the vigilance for CKD. Nevertheless, screening for renal in-
sufficiency is presently still substandard, even in patients at
risk [11]. The vigilance for renal insufficiency is still insuffi-
cient in general practitioners [14–16] as well as in medical
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specialists [5, 17], leading to delayed diagnosis and late re-
ferral to a nephrologist [18], which can result in inadequate
treatment [16, 19, 20] with possible impact on morbidity
and mortality [21].
The goal of the present study was to examine if an in-
creased vigilance for CKD in hospitalised patients results
in a quicker referral to the nephrology outpatient clinic,
a better follow-up and finally an improved outcome.
More specifically, we explored whether there was a dif-
ference in dialysis-free survival and mortality rate.
Methods
The present study was a single center study performed in
the Ghent University Hospital (Belgium). Subjects were
enrolled over a period of 100 days, between November
2013 and February 2014. Patients, hospitalised on a se-
lected number of medical wards in the hospital (thoracic
and vascular surgery, cardiac surgery, cardiology, endo-
crinology, infectious diseases, dermatology and geriatrics)
with an eGFR < 45 ml/min/1.73 m2 (according to CKD-
EPI), were identified on a daily basis by a computer query
program. The following exclusion criteria were used:
patients with advanced dementia, patients in a palliative
situation or having an end-stage organ failure, patients re-
ceiving any form of renal replacement therapy (peritoneal
dialysis, haemodialysis or kidney transplantation) and pa-
tients with acute kidney injury (AKI), documented by a
recent blood analysis, taken less than 3 months before
identification by the computer program, showing an eGFR
> 60 ml/min/1.73 m2.
All patients provided informed consent. An eGFR
measurement predating the current test for at least
3 months was obtained through search in the health re-
cords or by contacting the general practitioner to define
the CKD status of the patient. Patients were interviewed
about their awareness of CKD, follow-up by a nephrolo-
gist and inclusion in a care path. Patients and their gen-
eral practitioner were subsequently informed about renal
insufficiency, the presence of CKD and the possibility of
inclusion in a care path. Three and twelve months after
inclusion in the study, we checked if the patient had re-
ceived a consultation on the nephrology outpatient clinic
and whether a care path was initiated by contacting their
general practitioner and/or nephrology outpatient clinic.
In addition, the evolution of the kidney function and the
outcome (initiation of dialysis and mortality from any
cause) were recorded.
The primary endpoint of this study was whether the
increased vigilance for CKD led to a higher number of
patients referred to a nephrology outpatient clinic
(within three months), receiving follow-up by a neph-
rologist and included in a care path. The secondary end-
point of the study was a combined endpoint of need for
dialysis and mortality from any cause, reached between
three months and one year after inclusion in the study.
Statistical analyses were performed using MedCalc
(MedCalc, Ostend, Belgium). Differences between groups
were evaluated using the Student’s t-test and the Fisher’s
exact test with a two-tailed p-value. A p-value < 0.05 was
considered a priori to be statistically significant.
Results
During the inclusion period, 115 patients were identified
with an eGFR < 45 ml/min/1.73 m2(Fig. 1). A total of 43
patients were excluded: 3 patients already received dialy-
sis, ten patients had advanced dementia, an end-stage
organ failure or received palliative care and 30 patients
had AKI. The final cohort thus consisted of 72 patients
(51 males and 21 females, mean age: 76.6 ± 8.5 years)
with a mean eGFR of 33.9 ± 6.9 ml/min/1.73 m2.
Fifty-four patients (54/72) had proven CKD with an
eGFR consistently < 45 ml/min/1.73 m2 during at least
three months before inclusion, of which 36 had CKD
stage 3b (eGFR: 30–45 ml/min/1.73 m2) and 18 CKD
stage 4 (eGFR: 15–30 ml/min/1.73 m2). Only 65% (35/
54) of patients with CKD stage 3b or 4 were aware of
suffering from renal failure. Half of the patients with
CKD stage 3b or 4 (27/54) were never referred to a
nephrologist, 9% (5/54) was once referred to a nephrolo-
gist before but was no longer in follow-up, and only 41%
(22/54) was followed by a nephrologist on a regularly
basis. The number of patients who consulted a neph-
rologist at least once (13/18 vs 14/36; p = 0.042) or who
were still followed by a nephrologist (11/18 vs 11/36; p
= 0.042) was significantly higher in the group of patients
with CKD stage 4 in comparison with CKD stage 3b, re-
spectively. In the group of 32 patients with CKD, who
were not followed by a nephrologist before inclusion,
only 22% (7/32) was visited by a nephrologist during
their hospitalization on request of their treating phys-
ician. In five patients (5/54) follow-up after inclusion
was not possible due to completion of the secondary
endpoint or a palliative stage within three months after
inclusion. None of them was in follow-up by a nephrolo-
gist before inclusion.
Eighteen patients (18/72) did not had a proven ad-
vanced CKD at the time of inclusion, but were possibly
evolving into a CKD stage 3b. 16/18 patients had never
consulted a nephrologist before and had no knowledge
of any renal impairment. In six patients (6/18), follow-
up after inclusion was not possible due to completion of
the secondary endpoint or a palliative stage within three
months after inclusion. Of the remaining 12 patients, six
evolved to a CKD stage 3b.
Three months after inclusion (Fig. 2), 55 patients
(mean age: 76.7 ± 8.0 years, 69% males) were diagnosed
with CKD (mean eGFR: 34.5 ± 7.0 ml/min/1.73 m2).
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Fig. 1 Patient inclusion and vigilance for CKD. RRT, number of patients who received renal replacement therapy at time of inclusion; PALLIATIVE /
EOF, number of patients in a palliative stage or with end organ failure at time of inclusion; DEMENTIA, number of patients with dementia at time
of inclusion; AKI, number of patients with acute kidney injury
Fig. 2 Referrral status after 3 months and outcome after 1 year
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Seventeen patients (17/72) could not be referred or re-
ceive follow-up due to completion of the secondary end-
point or meeting one of the exclusion criteria within
three months after inclusion. Thirty three (33/55) pa-
tients were not yet followed by a nephrologist before
their inclusion. The kidney function of the CKD patients
who were not yet followed by a nephrologist before in-
clusion was significantly higher than the eGFR of the 22
patients who were already in follow-up (36.9 ± 5.8 ml/
min/1.73 m2 vs 30.9 ± 7.1 ml/min/1.73 m2, p = 0.001).
More than half of these patients (17/33), consulted a
nephrologist within three months after inclusion and
started a care path. The proportion of patients in follow-
up increased significantly from 41% (22/54) to 71% (39/
55) within three months after inclusion (p = 0.002), an
increase with 74%. One patient consulted a nephrologist
and started a care path six months after inclusion. The
other fifteen patients (15/33) did not visit a nephrologist.
Comparison of the outcome one year after inclusion in
CKD patients, not yet followed by a nephrologist before,
shows that the need to start dialysis and/or mortality
rate was significantly lower in the CKD patients who
were referred quickly, stayed in follow-up and started a
care path, compared with CKD patients who did not (0/
17 vs 5/15; p = 0.015). The compared groups did not dif-
fer significantly in gender, age, eGFR, number of patients
with a therapy restriction or number of patients who
stayed in a home care facility (Table 1). In addition, the
need to start dialysis and/or mortality rate one year after
inclusion was significantly lower in CKD patients who
were followed at the nephrology department compared
with the CKD patients who did not (2/38 vs 6/16; p =
0.006). Again, the compared groups did not differ signifi-
cantly in gender, age, eGFR, number of patients with a
therapy restriction or number of patients who stayed in
a home care facility (Table 2).
Discussion
This study reveals that in patients admitted to a tertiary
care hospital, CKD is unacknowledged in a substantial
number of patients. These data are supported by previous
findings in European populations. In the UK, nearly 85%
of patients with CKD, defined as a serum creatinine of >
2.03 mg/dl in men and > 1.53 mg/dl in women, were not
in follow-up [4]. In Northern Ireland, only a minority of
patients with a serum creatinine > 1.7 mg/dl were referred
to a nephrologist [22]. Also in Germany, relatively few
patients (39%) with CKD-stage 4 were followed with a
nephrologist [23].
Vigilance for renal insufficiency increases significantly
in more advanced CKD stages. Among patients with
CKD stage 3b, 69% was not followed by a nephrologist
vs 39% among patients with CKD stage 4. The observed
difference in vigilance for CKD according to the CKD
stage is consistent with the literature [19]. More than a
third of the CKD patients in the present study were not
aware of their renal insufficiency, although the kidney
function was measured at previous time points. This is
in line with the results of a British study, where 31% of
the patients with CKD stage 3B, 4 or 5 were unaware of
their disease [3].
The underlying reasons why advanced CKD remains
out of scope in so many patients are presumably multi-
factorial (1): several guidelines concerning when to refer
to a nephrologist offer conflicting information [24] or
are subject to national [25, 26] or regional [27] related
measures and agreements (2), these guidelines are often
insufficiently known by clinical practioners [17, 19, 21,
28, 29] and (3) the evidence of the published guidelines
is rather scarce.
This study has succeeded to detect patients with ad-
vanced CKD not yet followed by a nephrologist, and to
inform this group of patients and their general practi-
tioners about renal insufficiency, the presence of CKD
and the possibility for inclusion in a care path. In this
Table 1 Characteristics and outcome of patients who were
referred < 3 months after inclusion vs patients who were never
referred
Referred < 3
months +
follow-up
Not referred -
No follow-up
P-value
Total number of patients 17 15
eGFR (mean) 38.6 (+/− 4.4) 35.8 (+/− 6.0) p = 0.151
Age (mean) 74.9 (+/− 8.4) 78.7 (+/− 8.0) p = 0.224
Males/females 12/5 10/5 p = 1.00
Lives in care facility:
Yes/No
0/17 3/12 p = 0.092
Therapy restriction:
Yes/No
2/15 2/13 p = 1.00
Need of dialysis or
died within 1 year
after inclusion: Yes/No
0/17 5/10 p = 0.015
Table 2 Characteristics and outcome of patients who were in
follow-up with a nephrologist vs patients who were not
Follow-up No follow-up P-value
Total number of patients 38 16
eGFR (mean) 34.6 (+/− 6.9) 34.8 (+/− 7.2) p = 0.931
Age (mean) 75.6 (+/− 8.0) 78.9 (+/− 8.1) p = 0.168
Males/females 27/11 10/6 p = 0.540
Lives in care facility:
Yes/No
1/37 3/13 p = 0.073
Therapy restriction:
Yes/No
4/34 2/14 p = 1.00
Need of dialysis or
died within 1 year
after inclusion: Yes/No
2/36 6/10 p = 0.006
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way, the vigilance for renal insufficiency was augmented,
creating a higher alertness for conditions interacting
with a declining kidney function. In slightly more than
half of the newly discovered patients with advanced
CKD, a care path was initiated after discharge, leading to
a significant augmentation of the number of patients
with CKD in follow-up by a nephrologist.
In patients where the intervention did not lead to
follow-up by a nephrologist, a significant higher need for
dialysis and/or increased mortality rate in the year after
inclusion was observed. This is in line with previous lit-
erature. In a prospective British study, CKD patients
(serum creatinine ≥2.03 mg/dl in men and ≥ 1.53 mg/dl
in women; equivalent to an eGFR < 43 ml/min/1.73m2
and a mean eGFR of 28.5 ml/min/1.73m2) who were not
followed by a nephrologist, showed a significantly higher
mortality [4]. In a retrospective study of CKD patients,
defined as a serum creatinine of > 1.4 mg/dl, a better
survival of patients with CKD stage 3 and 4 was noted
in those who received nephrology follow-up [30]. A
similar finding was found in diabetic veterans with CKD
stage 3 and 4 [31].
The majority of general practitioners feel that they
have not received adequate training regarding time or
indications for referral of patients with progressive kid-
ney failure [32]. Increasing the vigilance for renal insuffi-
ciency as presented in this study is trying to provide a
higher level of involvement and information, in both the
patient and their physicians, with the goal of promoting
compliance and follow-up.
Despite the fact that there was no statistically difference
in age, gender or eGFR between the compared groups, des-
pite the exclusion of patients with advanced dementia and
patients in a final palliative situation or with an end-stage
organ failure as well as the exclusion of patients who
achieved the secondary endpoint during the first three
months after inclusion, a selection bias could still be re-
sponsible for the difference in achieving the secondary
endpoint. Nevertheless, the number of patients with a ther-
apy restriction and the number of patients who stayed in a
home care facility, did not differ significantly between these
groups. The major limitation of the study is its observa-
tional nature. Although demographic, clinical and bio-
chemical characteristics were similar between the groups,
it is conceivable that more compliant patients are more
likely to present for further follow-up. Poor compliance is
responsible for 42% of the late referrals [33] and may have
contributed to the observed differences in survival. In
addition, the decision by physicians not to refer the patient
for nephrological follow-up is often practiced for reasons
of existing co-morbidities [34]. Since we did not correct for
all comorbid conditions, comorbidity may have further
biased the results at the disadvantage of the patients that
were not referred. A further limitation is the small sample
size and the single center design of the study. The present
findings should therefore be confirmed in a larger multi-
center study.
Conclusion
The vigilance for renal insufficiency of both general
practitioners and medical specialists remains insufficient.
By detecting and informing patients with advanced
CKD, a higher awareness of the disease in both patients
and physicians is obtained, leading to a significant
quicker referral to and follow up by a nephrologist. The
combined endpoint of mortality from any cause and the
need for dialysis was significantly lower in patients who
were referred early to the nephrology outpatient clinic
and followed by a nephrologist.
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